Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
With FDA nod, Gilead adds twice-yearly option to PrEP landscape
The drug, branded as Yeztugo, becomes the longest-acting agent in HIV prevention.
Zoey Becker
Jun 18, 2025 2:32pm
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Gilead bolsters Trodelvy with first-line breast cancer win
May 31, 2025 8:00am
Gilead's Trodelvy chalks up another phase 3 breast cancer win
May 23, 2025 10:10am
Gilead tees up $11B in new US manufacturing, R&D investments
May 8, 2025 6:25am
Gilead inks $202M deal to resolve long-running kickbacks case
Apr 29, 2025 4:15pm
